et al. Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS.
1999;13501- 507Link to Article
et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: an analysis using restriction-fragment-length polymorphisms. N Engl J Med.
1992;326231- 235Link to Article
PM Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis
in an immunocompetent patient. Tuber Lung Dis.
1995;76575- 577Link to Article
I Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. Adv Tuberc Res. 1976;191- 63
PE The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect.
1997;119183- 201Link to Article
et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med.
1989;320545- 550Link to Article
G Impact of the HIV epidemic on the spread of other diseases: the case of tuberculosis. AIDS.
S47- S56Link to Article
NJ Tuberculosis in sub-Saharan Africa: a regional assessment of the impact of the human immunodeficiency virus and National Tuberculosis Control Program quality. Tuber Lung Dis.
1996;77220- 225Link to Article
P Tuberculosis and HIV: current status in Africa. AIDS. 1997;11
GR The increasing burden of tuberculosis in rural South Africa: impactof the HIV epidemic. S Afr Med J. 1997;87447- 450
KM Mycobacterial disease in South African gold miners in the era of HIV infection. Int J Tuberc Lung Dis. 1999;3791- 798
E Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana. Int J Tuberc Lung Dis. 1999;34- 11
S Opportunistic infections in AIDS/HIV infected patients in Thailand. Thai AIDS J. 1992;4117- 122
et al. Spectrum of disease in Africans with AIDS in London. AIDS.
1996;101563- 1569Link to Article
KM Natural history and spectrum of disease in adults with HIV/AIDS in Africa. AIDS.
S43- S54Link to Article
et al. A prospective study of community-acquired bloodstream infections among febrile adults admitted to Mulago Hospital in Kampala, Uganda. J Acquir Immune Defic Syndr Hum Retrovirol.
1998;19484- 499Link to Article
LB Fatal Mycobacterium tuberculosis
bloodstream infections in febrile hospitalized adults in Dar es Salaam, Tanzania. Clin Infect Dis.
1998;26290- 296Link to Article
et al. Fever and human immunodeficiency virus infection as sentinels for emerging mycobacterial and fungal bloodstream infections in hospitalised patients >15 years old, Bangkok. J Infect Dis.
1999;18087- 92Link to Article
et al. Unrecognised Mycobacterium tuberculosis
bacteraemia among hospital inpatients in less developed countries. Lancet.
1999;3541159- 1163Link to Article
et al. A hospital-based prevalence survey of bloodstream infections in febrile patients in Malawi: implications for diagnosis and therapy. J Infect Dis.
2000;1811414- 1420Link to Article
et al. Morbidity and mortality in South African gold miners: impact of untreated HIV infection. Clin Infect Dis.
2002;341251- 1258Link to Article
et al. The spectrum of clinical and pathological manifestations of AIDS in a consecutive series of autopsied patients in Mexico. AIDS.
1992;6467- 473Link to Article
et al. A clinical and pathological comparison of the WHO and CDC case definitions for AIDS in Kinshasa, Zaire: is passive surveillance valid? AIDS.
1993;71241- 1245Link to Article
et al. The mortality and pathology of HIV infection in a west African city. AIDS.
1993;71569- 1579Link to Article
et al. Autopsy findings in 70 AIDS patients who died in a department of pneumology in Ivory Coast: impact of tuberculosis. Med Trop (Mars). 1995;55252- 254
et al. Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya. J Acquir Immune Defic Syndr.
2000;2423- 29Link to Article
et al. Tuberculosis and the HIV epidemic: increasing annual risk of infection in Kenya, 1986-1996. AmJ Public Health.
1999;891078- 1082Link to Article
et al. Spread of strain W, a highly drug-resistant strain of Mycobacterium tuberculosis
, across the United States. Clin Infect Dis.
1999;2985- 92Link to Article
et al. A city-wide outbreak of a multiple-drug-resistant strain of Mycobacterium tuberculosis in New York. Int J Tuberc Lung Dis. 1997;1115- 121
et al. for the Italian Multidrug-Resistant Tuberculosis Outbreak Study Group, An outbreak of multidrug-resistant tuberculosis involving HIV-infected patients of two hospitals in Milan, Italy. AIDS.
1998;121095- 1102Link to Article
et al. Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires. J Infect Dis.
1997;176637- 642Link to Article
LA Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampicin. N Engl J Med.
1993;328527- 532Link to Article
BG Criteria for the control of drug-resistant tuberculosis. Proc Natl Acad Sci U S A.
2000;978180- 8185Link to Article
MC Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA.
1999;282677- 686Link to Article
D Childhood human immunodeficiency virus and tuberculosis co-infections: reconciling conflicting data. Int J Tuberc Lung Dis. 1998;2844- 851
Joint United Nations Programme on HIV/AIDS, Report on the Global HIV/AIDS Epidemic, June 2000. Geneva, Switzerland UNAIDS/WHO2000;13E
World Health Organization, Global Tuberculosis Control. Geneva, Switzerland World Health Organization2001;Publication WHO/CDS/TB/2001.287.
A Health sector priorities review: tuberculosis. Jamison
WHDisease Control Priorities in Developing Countries New York, NY Oxford University Press1993;
United Nations Population Division, ComprehensiveTables. New York, NY United Nations2001;World Population Prospects, 2000 Revision vol 1
United Nations Population Division, Sex and Age Distribution of the World Population. New York, NY United Nations2001;World Population Prospects, 2000 Revision vol 2
HL The Epidemiologic Basis of Tuberculosis Control. Paris, France International Union Against Tuberculosis and Lung Disease1999;63- 87
S Private doctors and tuberculosis control in India. Tuber Lung Dis.
1993;74332- 337Link to Article
Collaborative Group for the Study of Tuberculosis in Spain, Epidemiological trends of tuberculosis in Spain from 1989 to 1992. Tuber Lung Dis.
1995;76522- 525Link to Article
et al. Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998. Thorax.
2001;56173- 179Link to Article
Centers for Disease Control and Prevention, Reported Tuberculosis in the United States, 1999. Atlanta, Ga US Dept of Health and Human Services2000;
Centers for Disease Control and Prevention, National HIV Prevalence Surveys, 1997 (Summary). Atlanta, Ga US Dept of Health and Human Services1998;
et al. Tuberculosis and human immunodeficiency virus infection in west Burkina Faso: clinical presentation and clinical evolution. Int J Tuberc Lung Dis. 1997;168- 74
P Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients. Am J Respir Crit Care Med.
1999;159733- 740Link to Article
et al. The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia. J Trop Med Hyg. 1993;961- 11
et al. A case control study on human immunodeficiency virus-1 (HIV-1) infection as a risk factor for tuberculosis and leprosy in western Kenya. Tuber Lung Dis.
1993;74377- 381Link to Article
Van den Broek
et al. HIV-1 infection as a risk factor for the development of tuberculosis: a case-control study in Tanzania. Int J Epidemiol.
1993;221159- 1165Link to Article
et al. Impact of the HIV epidemic on trends in tuberculosis in Abidjan, Côte d'Ivoire. Tuber Lung Dis.
1995;7611- 16Link to Article
BR Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade. Clin Infect Dis.
1996;22683- 704Link to Article
K Epidemiology of Tuberculosis: Selected Papers. The Hague, the Netherlands Royal Netherlands Tuberculosis Association (KNCV)1991;
K The relationship between the risk of tuberculous infection and the risk of developing infectious tuberculosis. Bull Int Union Tuberc. 1985;60117- 119
HE Post-sanatorium tuberculosis survival rates in Minnesota. Public Health Rep.
1941;56895- 907Link to Article
National Tuberculosis Institute Bangalore, Tuberculosis in a rural population of South India: a five-year epidemiological study. Bull World Health Organ. 1974;51473- 488
W Die Fallen von Lungentuberkulose in der aarganuischen Heilstatte Barmelweid aus den Jahren 1912-1927. Der Aarganuischen Heilstatte Barmelweid. 1930;345- 379
Centers for Disease Control and Prevention, Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons: Florida and New York, 1988-1991. MMWR Morb Mortal Wkly Rep. 1991;40585- 591
P Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med.
1991;324289- 294Link to Article
TR The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA.
1996;2761223- 1238Link to Article
et al. Negative predictors of survival in HIV-infected patients with culture-confirmed pulmonary tuberculosis. Infection.
1999;27331- 334Link to Article
et al. Predictors of survival in HIV-infected tuberculosis patients. AIDS.
1996;10269- 272Link to Article
J Site of disease and opportunistic infection predict survival in HIV-associated tuberculosis. AIDS.
1997;11455- 460Link to Article
et al. Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba Hospital, Malawi. Trans R Soc Trop Med Hyg.
1998;92343- 347Link to Article
A Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS.
2001;15143- 152Link to Article
et al. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire. Lancet.
1995;345607- 610Link to Article
et al. Autopsy-proven causes of death in HIV-infected patients treated for tuberculosis in Abidjan, Côte d'Ivoire. AIDS.
1995;91251- 1254Link to Article
KM Factors associated with an increased case-fatality rate in HIV-infected and non-infected South African gold miners. Int J Tuberc Lung Dis. 2000;4705- 712
K Overview and epidemiologic assessment of the current global tuberculosis situation with an emphasis on control in developing countries. Rev Infect Dis.
S339- S346Link to Article
DA The fate of pulmonary tuberculosis under various treatment programmes. Bull Int Union Tuberc. 1978;5370- 75
et al. Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis. Lancet.
1991;337627- 630Link to Article
et al. Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis. Int J Tuberc Lung Dis. 1997;1446- 453
et al. Cohort study of human immunodeficiciency virus infection in patients with tuberculosis in Nairobi, Kenya. Am J Respir Crit Care Med. 1992;146849- 854
et al. Infection and morbidity in patients with tuberculosis in Nairobi, Kenya. AIDS.
1993;71469- 1474Link to Article
et al. Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. Lancet.
1994;3441323- 1328Link to Article
et al. The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia. Trans R Soc Trop Med Hyg.
1995;8978- 82Link to Article
et al. Two-year follow-up of persons with HIV-1- and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa. AIDS.
1995;91185- 1191Link to Article
Van den Broek
M Impact of human immunodeficiency virus infection on the outcome of treatment and survival of tuberculosis patients in Mwanza, Tanzania. Int J Tuberc Lung Dis. 1998;2547- 552
et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial. Lancet.
1999;3531469- 1475Link to Article
D Relapse and mortality among HIV-infected and uninfected patients with tuberculosis successfully treated with twice weekly directly observed therapy in rural South Africa. AIDS.
1999;131543- 1547Link to Article
et al. Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy. J Acquir Immune Defic Syndr.
2001;26326- 331Link to Article
et al. Differential impact of combined antiretroviral therapy on the survival of Italian patients with specific AIDS-defining illnesses. J Acquir Immune Defic Syndr.
2000;25451- 458Link to Article
et al. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS.
2002;1675- 83Link to Article
EL Impact of HIV infection on rates of recurrence after treatment for tuberculosis in South African gold miners. Int J Tuberc Lung Dis. 2000;4455- 462
D Impact of the human immunodeficiency virus epidemic on mortality among adults with tuberculosis in rural South Africa, 1991-1995. Int J Tuberc Lung Dis. 1998;2919- 925
et al. High mortality rates in tuberculosis patients in Zomba Hospital, Malawi, during 32 months of follow-up. Trans R Soc Trop Med Hyg.
2000;94305- 309Link to Article
P HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet.
2001;3581687- 1693Link to Article
SS Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City. Clin Infect Dis.
2001;331762- 1769Link to Article
et al. Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons. AIDS.
1999;131899- 1904Link to Article
P Tuberculosis patients and practitioners in private clinics in India. Int J Tuberc Lung Dis. 1998;2324- 329
SB Tuberculosis and HIV infection in sub-Saharan Africa. JAMA.
1992;2681581- 1587Link to Article
et al. Mortality rates and recurrent rates of tuberculosis in patients with smear-negative pulmonary tuberculosis and tuberculous pleural effusion who have completed treatment. Int J Tuberc Lung Dis. 2000;4968- 974
FM Treatment outcome of patients with smear-negative and smear-positive pulmonary tuberculosis in the National Tuberculosis Control Programme, Malawi. Trans R Soc Trop Med Hyg.
1999;93443- 446Link to Article
et al. Efficacy of an unsupervised ambulatory treatment regimen for smear-negative pulmonary tuberculosis and tuberculous pleural effusion in Malawi. Int J Tuberc Lung Dis. 1999;3402- 408
SB ‘Smear-negative' pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence. Int J Tuberc Lung Dis. 2001;5847- 854
World Health Organisation, International Union Against Tuberculosis and Lung Diseases. Royal Netherlands Tuberculosis Association revised international definitions of tuberculosis controlInt J Tuberc Lung Dis 2001;5213- 215
Tanzania Tuberculin Survey Collaboration, Tuberculosis control in the era of the HIV epidemic: risk of tuberculosis infection in Tanzania, 1983-1998. Int J Tuberc Lung Dis. 2001;5103- 112
et al. Tuberculosis: associations with HIV and socioeconomic status in rural Malawi. Trans R Soc Trop Med Hyg.
2000;94500- 503Link to Article
et al. Trend in HIV prevalence among tuberculosis patients in Tanzania, 1991-1998. Int J Tuberc Lung Dis. 2001;5405- 412
US Bureau of the Census, Population Division, International Programs Center HIV/AIDS Surveillance Database, July 2000. Washington, DC US Bureau of the Census2000;
World Health Organization, Global Tuberculosis Control: Surveillance, Planning and Financing. Geneva, Switzerland World Health Organization2002;Publication WHO/CDS/TB/2002.295.
et al. Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults. AIDS.
2001;15215- 222Link to Article
KMfor the Adult/Adolescent Spectrum of HIV Disease Group, HIV-associated tuberculosis in the era of highly active antiretroviral therapy. IntJ Tuberc Lung Dis. 2000;41026- 1031
et al. Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS.
2000;141985- 1991Link to Article
J Mycobacterium tuberculosis and human immunodeficiency virus co-infection in intravenous drug users on admission to prison. Int J Tuberc Lung Dis. 2000;441- 46
et al. HIV/AIDS among African Americans: progress or progression? AIDS.
2001;141237- 1248Link to Article
et al. for the World Health Organization-International Union Against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance, Global trends in resistance to antituberculosis drugs. N Engl J Med.
2001;3441294- 1303Link to Article
B Update on the epidemics of HIV and other sexually transmitted infections in the newly independent states of the former Soviet Union. AIDS.
S75- S84Link to Article
et al. Human immunodeficiency virus-related tuberculosis and primary drug resistance in Bangkok, Thailand. Int J Tuberc Lung Dis. 2000;4537- 543
BG Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis.
2001;1851197- 1202Link to Article
et al. HIV infection and silicosis: the impact of two potent risk factors on mycobacterial disease incidence in South African miners. AIDS.
2000;142759- 2768Link to Article
EE High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA.
1992;268504- 509Link to Article
EE The incidence of tuberculosis in drug users with small tuberculin reaction sizes. Int J Tuberc Lung Dis. 2001;5707- 711
et al. Tuberculosis and HIV infection among female inmates in Sao Paulo, Brazil: a prospective cohort study. J Acquir Immune Defic Syndr Hum Retrovirol.
1996;13177- 183Link to Article
et al. A retrospective cohort study of the risk of tuberculosis among women of childbearing age with HIV infection in Zaire. Am Rev Respir Dis.
1991;143501- 504Link to Article
et al. Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women. Am Rev Respir Dis.
1992;1461439- 1444Link to Article
et al. Four years of natural history of HIV-1 infection in African women: a prospective cohort study in Kigali (Rwanda), 1988-1993. J Acquir Immune Defic Syndr Hum Retrovirol.
1995;9415- 421Link to Article
Jr Epidemiology of tuberculosis in the United States. Epidemiol Rev. 1989;1179- 98
BG Evaluating the impact of tuberculosis control: number of deaths prevented by short-course chemotherapy in China. Int J Epidemiol.
2000;29558- 564Link to Article
et al. The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru. J Infect Dis.
2001;184473- 478Link to Article
et al. Decreasing incidence of HIV and sexually transmitted diseases in young Thai men: evidence for success of the HIV/AIDS control and prevention program. AIDS.
1998;12F29- F36Link to Article
K Effectiveness of HIV prevention interventions in developing countries. AIDS.
S68- S84Link to Article
M Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials. Lancet.
2000;3551981- 1987Link to Article
The Voluntary HIV-1 Counseling and Testing Efficacy Study Group, Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. Lancet.
2000;356103- 112Link to Article
MA Tuberculosis in New York City: turning the tide. N Engl J Med.
1995;333229- 333Link to Article
RE Will DOTS do it? a reappraisal of tuberculosis control in countries with high rates of HIV infection. Int J Tuberc Lung Dis. 1999;3457- 465